Flurazepam Hydrochloride Capsule — FDA Drug Shortage

Current — Rising Pharma Holdings, Inc.

The FDA lists a drug shortage record for Flurazepam Hydrochloride Capsule (capsule) from Rising Pharma Holdings, Inc. with status Current. The shortage was first posted on Aug 3, 2022. Reported reason: Regulatory delay

Shortage details

Status
Current
Company
Rising Pharma Holdings, Inc.
Package NDC
0378-4415-01
Dosage Form
Capsule
Presentation
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)
Initial Posting
Aug 3, 2022

Reason

Regulatory delay

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.